Welcome to LookChem.com Sign In|Join Free
  • or
2-Thiazolamine, N-(4-methoxyphenyl)-4-(4-pyridinyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

61889-63-2

Post Buying Request

61889-63-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61889-63-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61889-63-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,8 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 61889-63:
(7*6)+(6*1)+(5*8)+(4*8)+(3*9)+(2*6)+(1*3)=162
162 % 10 = 2
So 61889-63-2 is a valid CAS Registry Number.

61889-63-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-methoxyphenyl)-4-pyridin-4-yl-1,3-thiazol-2-amine

1.2 Other means of identification

Product number -
Other names (4-methoxy-phenyl)-(4-pyridin-4-yl-thiazol-2-yl)-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61889-63-2 SDS

61889-63-2Downstream Products

61889-63-2Relevant academic research and scientific papers

HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT

-

Page/Page column 91, (2009/10/22)

Provided herein are novel heteroaryl compounds, compositions comprising the compounds, and methods of treatment or prevention comprising administration of the compounds. The compounds are effective in the targeting of cells defective in the von Hippel-Lindau gene and in inducing autophagic cell death. The methods are directed to treating or preventing diseases such as cancer, and in particular cancers resulting from von Hippel-Lindau disease. The compounds of the invention may be administered in combination with another therapeutic agent.

Mitotic kinesin inhibitors

-

Page/Page column 21, (2010/02/13)

The present invention relates to substituted thiazole derivatives that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin and MCAK activity, and for inhibiting KSP kinesin and MCAK. The invention al

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 61889-63-2